Melissa L. Larson

High-Dose Vincristine Sulfate Liposome Injection for Advanced, Relapsed, and Refractory Adult Philadelphia Chromosome–Negative Acute Lymphoblastic Leukemia

Susan O’Brien, Gary J. Schiller, John Lister et al. · Journal of Clinical Oncology · 2012 · 188 citations

Pharmacy, Oncology, Pharmacotherapy +17

Phase II, multicenter, randomized trial of CPX‐351 (cytarabine:daunorubicin) liposome injection versus intensive salvage therapy in adults with first relapse AML

Jörge E. Cortes, Stuart L. Goldberg, Eric J. Feldman et al. · Cancer · 2014 · 172 citations · Full text

Medicine, Oncology, Pharmacology +13

Structural racism is a mediator of disparities in acute myeloid leukemia outcomes

Ivy Abraham, Garth H. Rauscher, Anand Patel et al. · Blood · 2022 · 86 citations · Full text

Public Health, Hematology, Oncology +14

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Se young Han, Krzysztof Mrózek, Jenna Voutsinas et al. · Blood Advances · 2021 · 48 citations · Full text

Life Sciences, Genetics, Hematology +17

Aggressive disease defined by cytogenetics is associated with cytokine dysregulation in CLL/SLL patients

Reem Karmali, Laura A. Paganessi, Robin R. Frank et al. · Journal of Leukocyte Biology · 2012 · 15 citations · Full text

Life Sciences, Immunology, Oncology +17